• Profile
Close
Question

What is the most common grade ≥3 adverse event associated with TAS-102 (trifluridine/tipiracil) plus bevacizumab in your heavily pretreated patients with metastatic colorectal cancer (CRC)?

x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay